BIOPOL — BIOPOL CHEMICALS Income Statement
0.000.00%
- IN₹996.26m
- IN₹1.07bn
- IN₹491.28m
Annual income statement for BIOPOL CHEMICALS, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IAS | IAS | IAS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 193 | 174 | 491 |
| Cost of Revenue | |||
| Gross Profit | 29 | 28.1 | 88.6 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 178 | 156 | 427 |
| Operating Profit | 15.1 | 18.4 | 64.6 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | 7.19 | 17.1 | 58 |
| Provision for Income Taxes | |||
| Net Income After Taxes | 5.38 | 12.8 | 43.4 |
| Net Income Before Extraordinary Items | |||
| Net Income | 5.38 | 12.8 | 43.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | 5.38 | 12.8 | 43.4 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 0.68 | 1.62 | 5.49 |